Nuevolution to present at three investor conferences in September 2017
Stockholm, 11 September 2017 -- Nuevolution AB (publ) (NUE.ST), a leading small-molecule drug-discovery biotech company, today announced that it will be presenting at three investor conferences in the US, Sweden and Denmark in September. First, the company will present at the 19th Annual Rodman & Renshaw Global Investment Conference. The conference will take place on 11-12 September 2017 at the Lotte New York Palace Hotel in New York City. Henrik D. Simonsen, CFO of Nuevolution AB (publ), will provide an overview of the Company’s business during the live presentation on 12 September